Jordan vs Saudi Arabia: HIV-positive TB patients on ART (antiretroviral therapy)
Jordan
100.0%
in 2024
Saudi Arabia
100.0%
in 2024
Jordan rank
1st
Saudi Arabia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Jordan
- Saudi Arabia
How they compare
Jordan currently reports 100.0% against 100.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2007 it was Saudi Arabia ahead.
Jordan ranks 1st and Saudi Arabia ranks 1st of 144 countries.
Jordan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jordan | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 98.0% | 2.0% | Jordan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Jordan or Saudi Arabia?
- Jordan, at 100.0% against 100.0% in Saudi Arabia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Jordan and Saudi Arabia?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Saudi Arabia?
- 5 years are reported by both, from 2007 to 2024.
- How do Jordan and Saudi Arabia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Jordan ranks 1st and Saudi Arabia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.